Alerus Financial’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.14M | Sell |
85,086
-413
| -0.5% | -$44.4K | 0.66% | 32 |
|
|
2025
Q1 | $8.63M | Sell |
85,499
-4,901
| -5% | -$494K | 0.69% | 33 |
|
|
2024
Q4 | $8.07M | Sell |
90,400
-7,207
| -7% | -$644K | 0.62% | 37 |
|
|
2024
Q3 | $8.18M | Sell |
97,607
-3,898
| -4% | -$327K | 0.6% | 40 |
|
|
2024
Q2 | $7.82M | Sell |
101,505
-1,834
| -2% | -$141K | 0.58% | 42 |
|
|
2024
Q1 | $7.08M | Buy |
103,339
+37,051
| +56% | +$2.54M | 0.53% | 48 |
|
|
2023
Q4 | $3.83M | Buy |
+66,288
| New | +$3.83M | 0.31% | 77 |
|
|
2022
Q2 | – | Sell |
-6,782
| Closed | -$301K | – | 169 |
|
|
2022
Q1 | $301K | Sell |
6,782
-6,105
| -47% | -$271K | 0.03% | 160 |
|
|
2021
Q4 | $547K | Sell |
12,887
-28,343
| -69% | -$1.2M | 0.04% | 146 |
|
|
2021
Q3 | $1.79M | Sell |
41,230
-1,021
| -2% | -$44.3K | 0.16% | 120 |
|
|
2021
Q2 | $1.81M | Sell |
42,251
-3,607
| -8% | -$154K | 0.18% | 118 |
|
|
2021
Q1 | $1.77M | Sell |
45,858
-33,895
| -42% | -$1.31M | 0.19% | 109 |
|
|
2020
Q4 | $2.87M | Buy |
79,753
+18,330
| +30% | +$659K | 0.29% | 90 |
|
|
2020
Q3 | $2.35M | Buy |
61,423
+11,414
| +23% | +$436K | 0.26% | 93 |
|
|
2020
Q2 | $1.76M | Sell |
50,009
-1,863
| -4% | -$65.4K | 0.21% | 94 |
|
|
2020
Q1 | $1.69M | Buy |
51,872
+2,766
| +6% | +$90.3K | 0.23% | 92 |
|
|
2019
Q4 | $2.22M | Buy |
49,106
+319
| +0.7% | +$14.4K | 0.25% | 88 |
|
|
2019
Q3 | $1.99M | Buy |
48,787
+6,515
| +15% | +$265K | 0.26% | 86 |
|
|
2019
Q2 | $1.82M | Buy |
+42,272
| New | +$1.82M | 0.25% | 90 |
|